Standard Treatment and Specialist Care
At a Glance
The modern standard of care for penile cancer prioritizes organ-preserving surgeries, such as partial penectomy, and specialized lymph node management. Because this cancer is rare, it is highly recommended to seek treatment at a high-volume specialist center for the best outcomes.
When you are diagnosed with a rare cancer, the Standard of Care—the treatment that experts agree is most effective—is highly specialized. Because penile cancer is so infrequent, the “standard” isn’t just about what treatment you get, but where and who provides it. The goal of modern treatment is to cure the cancer while preserving as much function and tissue as possible [1][2].
Treating the Primary Tumor: Phallus Preservation
In the past, many penile cancers were treated with radical surgery (amputation). Today, the standard is organ-preserving complete resection whenever possible [1][3].
Common organ-sparing surgical approaches include:
- Glans Resurfacing: Removing the surface layer of the head of the penis and replacing it with a skin graft [1].
- Glansectomy: Removing the head of the penis but preserving the main body (shaft). This often allows for normal urination and sexual function [1][3].
- Partial Penectomy: Removing only the tip of the penis.
These approaches offer excellent functional results, though they require very close lifelong follow-up because there is a slightly higher risk that the cancer could return in the remaining tissue compared to more radical surgery [1][4].
Radiation Therapy as an Option
While surgery is the most common approach, radiation therapy (such as external beam radiation or brachytherapy, which places radioactive “seeds” directly into the tumor) is a legitimate organ-sparing alternative for certain primary tumors [5]. Radiation can also be used as an ‘adjuvant’ (additional) treatment directed at the lymph nodes after surgery, especially if the cancer has grown outside the lymph node capsule [5][6]. You should ask your care team if consulting with a radiation oncologist is appropriate for your stage.
Managing the Lymph Nodes
The most critical part of your treatment plan is managing the inguinal lymph nodes in your groin. Even if you cannot feel any lumps, there may be “microscopic” spread [7][8].
- For Non-Palpable Nodes (cN0): If your doctor cannot feel any lumps, you may be a candidate for Dynamic Sentinel Lymph Node Biopsy (DSNB). This is a specialized staging procedure that identifies and removes only the first few “sentinel” nodes that the cancer would likely reach first [9][10]. This minimizes the risk of severe leg swelling associated with larger surgeries [10].
- For Palpable or Bulky Nodes (cN+): If nodes are felt or seen on a scan, a full Inguinal Lymph Node Dissection (ILND) is the standard [8]. It is vital to know that ILND is a major surgery with significant side effects. Complications frequently include wound healing issues and lymphedema—severe, chronic swelling of the legs and scrotum due to disrupted lymph fluid drainage. You should ask your care team about physical therapy and compression garments before surgery to manage expectations and minimize these risks [11].
- Neoadjuvant Chemotherapy: If the nodal disease is bulky or fixed (stuck to nearby structures), your team may recommend chemotherapy before surgery. The TIP regimen (Paclitaxel, Ifosfamide, and Cisplatin) is commonly used to shrink the tumor and make surgery more successful [12][13].
The Importance of High-Volume Centers
Guidelines from major organizations like the NCCN and EAU strongly recommend centralization of care [2]. This means going to a “high-volume” specialist center.
- Better Outcomes: Surgeons who perform these procedures frequently (at least several times a month) have higher success rates and lower complication rates [14][11].
- Specialized Staging: Procedures like DSNB require specific radiological expertise that is often only available at major centers [15].
Preparation for Your First Specialist Visit
To make the most of your first appointment at a specialist center, you must bring:
- Original Pathology Slides: Not just the paper report, but the actual glass slides from your biopsy [16]. Your new hospital will need to review them under their own microscopes.
- Imaging Discs: A CD or digital access to all CT, MRI, or PET scans you have had.
- Operation Reports: Detailed notes from any previous procedures related to this diagnosis.
Common questions in this guide
Can penile cancer be treated without completely removing the penis?
What is a dynamic sentinel lymph node biopsy (DSNB)?
What are the side effects of an inguinal lymph node dissection (ILND)?
Why should I go to a high-volume center for penile cancer treatment?
What do I need to bring to my first appointment with a penile cancer specialist?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is your personal volume for penile-preserving surgeries and inguinal lymph node dissections per year?
- 2.Am I a candidate for a Dynamic Sentinel Lymph Node Biopsy, or do I require a full ILND?
- 3.If I need an ILND, what is your protocol for preventing and managing lymphedema after surgery?
- 4.Am I a candidate for radiation therapy (like brachytherapy) instead of surgery for my primary tumor?
- 5.Does my case require neoadjuvant chemotherapy before surgery, and which medical oncologist on your team specializes in this?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Organ-sparing partial glansectomy: an alternative surgical management for invasive penile carcinoma-case report.
Chan J, Espinales J, Valancy D, et al.
Translational andrology and urology 2024; (13(12)):2833-2839 doi:10.21037/tau-24-512.
PMID: 39816219 - 2
Centralization and Equitable Care in Rare Urogenital Malignancies: The Case for Penile Cancer.
Jakobsen JK, Pettaway CA, Ayres B
European urology focus 2021; (7(5)):924-928 doi:10.1016/j.euf.2021.09.019.
PMID: 34593356 - 3
Glansectomy and Reconstruction for Penile Cancer: A Systematic Review.
Pang KH, Muneer A, Alnajjar HM
European urology focus 2022; (8(5)):1318-1322 doi:10.1016/j.euf.2021.11.008.
PMID: 34903488 - 4
[Reconstructive surgery in penile cancer].
Sohn M, Dietrich M, Wirthmann A, Rieger UM
Der Urologe. Ausg. A 2018; (57(4)):428-434 doi:10.1007/s00120-018-0610-x.
PMID: 29536118 - 5
Management of Bulky Inguinal and Pelvic Lymph Nodes.
Zemp LW, Rudzinski JK, Pettaway CA, et al.
The Urologic clinics of North America 2024; (51(3)):335-345 doi:10.1016/j.ucl.2024.03.012.
PMID: 38925736 - 6
The role of radiotherapy in the management of squamous cell cancer of the penis.
Crook J
World journal of urology 2023; (41(12)):3913-3920 doi:10.1007/s00345-023-04683-7.
PMID: 37994970 - 7
Prophylactic inguinal lymphadenectomy for high-risk cN0 penile cancer: The optimal surgical timing.
Ma S, Zhao J, Liu Z, et al.
Frontiers in oncology 2023; (13()):1069284 doi:10.3389/fonc.2023.1069284.
PMID: 36895485 - 8
The Diagnosis and Treatment of Penile Cancer.
Hakenberg OW, Dräger DL, Erbersdobler A, et al.
Deutsches Arzteblatt international 2018; (115(39)):646-652.
PMID: 30375327 - 9
The surgical technique and protocol for dynamic sentinel node biopsy for penile cancer at a Southeast Asian regional hospital.
Lau W, Lim ICZY, Wong JCS, et al.
Translational andrology and urology 2024; (13(7)):1268-1277 doi:10.21037/tau-23-681.
PMID: 39100835 - 10
[Dynamic sentinel node biopsy in penile cancer. Indications, technique and results in a Spanish oncological center].
Gómez-Ferrer Á, Rubio J, Collado A, et al.
Archivos espanoles de urologia 2015; (68(6)):524-31.
PMID: 26179789 - 11
Impact of Examined Lymph Node Count and Lymph Node Density on Overall Survival of Penile Cancer.
Gao P, Zhu T, Gao J, et al.
Frontiers in oncology 2021; (11()):706531 doi:10.3389/fonc.2021.706531.
PMID: 34307174 - 12
Inguinal lymph node dissection for penile cancer: a contemporary review.
Teh J, Duncan C, Qu L, et al.
Translational andrology and urology 2020; (9(6)):3210-3218 doi:10.21037/tau.2019.08.37.
PMID: 33457292 - 13
Complete Remission of Locally Advanced Penile Squamous Cell Carcinoma after Multimodality Treatment.
Meng Y, Bernie HL, Weng TH, et al.
Rare tumors 2016; (8(4)):6651 doi:10.4081/rt.2016.6651.
PMID: 28191294 - 14
Centralization of Penile Cancer Management in the United States: A Combined Analysis of the American Board of Urology and National Cancer Data Base.
Matulewicz RS, Flum AS, Helenowski I, et al.
Urology 2016; (90()):82-8.
PMID: 26827845 - 15
Diagnostic precision of sentinel lymph node biopsy in penile cancer.
Ramos JG, Jaramillo DC, Sandoval D, et al.
Indian journal of urology : IJU : journal of the Urological Society of India 2019; (35(4)):282-286 doi:10.4103/iju.IJU_79_19.
PMID: 31619867 - 16
Penile cancer: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
Muneer A, Bandini M, Compérat E, et al.
ESMO open 2024; (9(7)):103481 doi:10.1016/j.esmoop.2024.103481.
PMID: 39089768
This page provides educational information about standard penile cancer treatments. It does not replace professional medical advice; always discuss your specific surgical and organ-preservation options with a specialized urologic oncologist.
Get notified when new evidence is published on Malignant tumor of penis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.